Stem Cell Therapy: A Great Leap Forward in Alzheimer’s Treatment

  • Nazish Tabassum
  • Chandra Bhan Yadav
  • Anshuman Singh
  • Vinod VermaEmail author


Alzheimer’s disease (AD) is a neurodegenerative disorder and one of the substantial socioeconomic and medical calamities of our time. It is characterized by progressive neurodegenerative disorder featuring dementia and cognitive impairment. It is caused by synaptic failure and the excessive aggregation of two types of misfolded proteins, namely, amyloid-β (Aβ) and tau protein. AD is a complex disease that affects neurons in different parts of the brain. The treatment of AD is difficult with currently available medications and treatment approaches due to inadequate knowledge of its etiology and versatile nature of its pathology. Stem cell holds a promising approach to regenerate the tissue systems and has been explored in various studies of neurodegenerative disorders and provides great research opportunity. Stem cell research-based therapies emit a new hope for AD treatment as a regenerative approach. This chapter focuses on recent advances in stem cell therapies according to cell types and pathophysiology of AD along with human clinical trials of stem cell therapies for the AD.


Stem cell Alzheimer’s disease Amyloid precursor protein 



This work is supported by SERB (EEQ/2018/000114) grant.

Disclosure of Potential Conflicts of Interest

The author(s) declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.


  1. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105(4):1815–1822. Scholar
  2. Allen S, Watson J, Dawbarn D et al (2011) The neurotrophins and their role in Alzheimer’s disease. Curr Neuropharmacol 9(4):559–573. Scholar
  3. Araki R, Uda M, Hoki Y et al (2013) Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494(7435):100. Scholar
  4. ARSI. Alzheimer’s and Related Disorders Society of India (ARDSI) (2010)Google Scholar
  5. Babaei P, Soltani Tehrani B, Alizadeh A (2012) Transplanted bone marrow mesenchymal stem cells improve memory in rat models of Alzheimer’s disease. Stem Cells Int 2012:369417. Scholar
  6. Blurton-Jones M, Kitazawa M, Martinez-Coria H et al (2009) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci 106(32):13594–13599. Scholar
  7. Brazelton TR, Rossi FM, Keshet GI et al (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290(5497):1775–1779. Scholar
  8. Chen J, Tang YX, Liu YM et al (2012) Transplantation of adipose-derived stem cells is associated with neural differentiation and functional improvement in a rat model of intracerebral hemorrhage. CNS Neurosci Ther 18(10):847–854. Scholar
  9. Choi SH, Kim YH, Hebisch M et al (2014a) A three-dimensional human neural cell culture model of Alzheimer’s disease. Nature 515(7526):274CrossRefGoogle Scholar
  10. Choi SS, Lee SR, Kim SU et al (2014b) Alzheimer’s disease and stem cell therapy. Exp Neurobiol 23(1):45–52. Scholar
  11. Cooper O, Hargus G, Deleidi M et al (2010) Differentiation of human ES and Parkinson’s disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol Cell Neurosci 45(3):258–266. Scholar
  12. Danysz W, Parsons CG, MÖbius HJ et al (2000) Neuroprotective and symptomatological action of memantine relevant for Alzheimer’s disease – a unified glutamatergic hypothesis on the mechanism of action. Neurotox Res 2(2–3):85–97CrossRefGoogle Scholar
  13. Duncan T, Valenzuela M (2017) Alzheimer’s disease, dementia, and stem cell therapy. Stem Cell Res Ther 8(1):111. Scholar
  14. Eckman CB, Eckman EA (2007) An update on the amyloid hypothesis. Neurol Clin 25(3):669–682. Scholar
  15. Esmaeilzade B, Nobakht M, Joghataei MT et al (2012) Delivery of epidermal neural crest stem cells (EPI-NCSC) to hippocamp in Alzheimer’s disease rat model. Iran Biomed J 16(1):1. Scholar
  16. Genin E, Hannequin D, Wallon D et al (2011) APOE and Alzheimer’s disease: a major gene with semi-dominant inheritance. Mol Psychiatry 16(9):903. Scholar
  17. Gutiérrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J et al (2013) Effects of intravenous administration of allogenic bone marrow-and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther 4(1):11. Scholar
  18. Holtman IR, Raj DD, Miller JA et al (2015) Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol Commun 3(1):31. Scholar
  19. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148(6):1204–1222. Scholar
  20. Imbimbo BP, Lombard J, Pomara N et al (2005) Pathophysiology of Alzheimer’s disease. Neuroimag Clin 15(4):727–753. Scholar
  21. Israel MA, Yuan SH, Bardy C et al (2012) Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells. Nature 482(7384):216CrossRefGoogle Scholar
  22. Kang JM, Yeon BK, Cho SJ et al (2016) Stem cell therapy for Alzheimer’s disease: A review of recent clinical trials. J Alzheimers Dis 54(3):879–889. Scholar
  23. Kern DS, Maclean KN, Jiang H et al (2011) Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice. Cell Transplant 20(3):371–379CrossRefGoogle Scholar
  24. Kim JY, Kim DH, Kim JH et al (2012a) Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaques. Cell Death Differ 19(4):680. Scholar
  25. Kim S, Chang KA, Park HG et al (2012b) The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer’s disease mice. PLoS One 7(9):e45757CrossRefGoogle Scholar
  26. Kooreman NG, Wu JC (2010) Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging. J R Soc Interface 7(Suppl 6):S753–S763. Scholar
  27. Krencik R, Weick JP, Liu Y et al (2011) Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nat Biotechnol 29(6):528. Scholar
  28. Lai MK, Tsang SW, Alder JT et al (2005) Loss of serotonin 5-HT 2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer’s disease. Psychopharmacology 179(3):673–677. Scholar
  29. Lee HJ, Lee JK, Lee H et al (2012) Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer’s disease mouse model through modulation of neuroinflammation. Neurobiol Aging 33(3):588–602. Scholar
  30. Lee JK, Jin HK, Bae JS (2009) Bone marrow-derived mesenchymal stem cells reduce brain amyloid-β deposition and accelerate the activation of microglia in an acutely induced Alzheimer’s disease mouse model. Neurosci Lett 450(2):136–141. Scholar
  31. Lin HAI, Bhatia R, Lal R et al (2001) Amyloid β protein forms ion channels: implications for Alzheimer’s disease pathophysiology. FASEB J 15(13):2433–2444. Scholar
  32. Maccioni RB, Farías G, Morales I, Navarrete L et al (2010) The revitalized tau hypothesis on Alzheimer’s disease. Arch Med Res 41(3):226–231. Scholar
  33. Malmersjö S, Liste I, Dyachok O et al (2009) Ca2+ and cAMP signaling in human embryonic stem cell–derived dopamine neurons. Stem Cells Dev 19(9):1355–1364. Scholar
  34. Marchetti C, Marie H (2011) Hippocampal synaptic plasticity in Alzheimer’s disease: what have we learned so far from transgenic models? Rev Neurosci 22(4):373–402. Scholar
  35. Mezey E, Chandross KJ, Harta G et al (2000) Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290(5497):1779–1782. Scholar
  36. Mössner R, Schmitt A, Syagailo Y et al (2000) The serotonin transporter in Alzheimer’s and Parkinson’s disease. In: Advances in research on neurodegeneration. Springer, Vienna, pp 345–350CrossRefGoogle Scholar
  37. Mu Y, Gage FH (2011) Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Mol Neurodegener 6(1):85. Scholar
  38. Nori S, Okada Y, Yasuda A et al (2011) Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci 108(40):16825–16830. Scholar
  39. Oh SH, Kim HN, Park HJ et al (2015) Mesenchymal stem cells increase hippocampal neurogenesis and neuronal differentiation by enhancing the Wnt signaling pathway in an Alzheimer’s disease model. Cell Transplant 24(6):1097–1109CrossRefGoogle Scholar
  40. Park D, Joo SS, Kim TK et al (2012) Human neural stem cells overexpressing choline acetyltransferase restore cognitive function of kainic acid-induced learning and memory deficit animals. Scholar
  41. Pearl JI, Kean LS, Davis MM et al (2012) Pluripotent stem cells: immune to the immune system? Sci Transl Med 4(164):164ps25. Scholar
  42. Pen AE, Jensen UB (2017) Current status of treating neurodegenerative disease with induced pluripotent stem cells. Acta Neurol Scand 135(1):57–72. Scholar
  43. Peroni D, Scambi I, Pasini A et al (2008) Stem molecular signature of adipose-derived stromal cells. Exp Cell Res 314(3):603–615. Scholar
  44. Perry EK, Tomlinson BE, Blessed G et al (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2(6150):1457–1459CrossRefGoogle Scholar
  45. Persson T, Popescu BO, Cedazo-Minguez A et al (2014) Oxidative stress in Alzheimer’s disease: why did antioxidant therapy fail? Oxidative Med Cell Longev. Scholar
  46. Prasher VP, Farrer MJ, Kessling AM et al (1998) Molecular mapping of Alzheimer-type dementia in Down’s syndrome. Ann Neurol 43(3):380–383. Scholar
  47. Qu T, Brannen CL, Kim HM et al (2001) Human neural stem cells improve cognitive function of aged brain. Neuroreport 12(6):1127–1132CrossRefGoogle Scholar
  48. Ra JC, Shin IS, Kim SH et al (2011) Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 20(8):1297–1308. Scholar
  49. Ramasamy R, Fazekasova H, Lam EWF et al (2007) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83(1):71–76. Scholar
  50. Reiss AB (2005) Cholesterol and apolipoprotein E in Alzheimer’s disease. Am J Alzheimers Dis Other Dement 20(2):91–96. Scholar
  51. Rosen KM, Moussa CEH, Lee HK et al (2010) Parkin reverses intracellular β-amyloid accumulation and its negative effects on proteasome function. J Neurosci Res 88(1):167–178. Scholar
  52. Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81(2):741–766. Scholar
  53. Selkoe DJ (2002) Alzheimer’s disease is a synaptic failure. Science 298(5594):789–791. Scholar
  54. Sotiropoulou PA, Perez SA, Gritzapis AD et al (2006) Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24(1):74–85. Scholar
  55. Sproul AA, Jacob S, Pre D et al (2014) Characterization and molecular profiling of PSEN1 familial Alzheimer’s disease iPSC-derived neural progenitors. PLoS One 9(1):e84547. Scholar
  56. Swerdlow RH (2007) Pathogenesis of Alzheimer’s disease. Clin Interv Aging 2(3):347PubMedPubMedCentralGoogle Scholar
  57. Tabassum N, Verma V, Yadav CB et al (2017) Tissue engineering in regenerative medicine. In: Stem cells from culture dish to clinic. Nova Science Publishers Inc, New York, pp 17–32Google Scholar
  58. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676. Scholar
  59. Takamatsu K, Ikeda T, Haruta M et al (2014) Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2. Stem Cell Res 13(3):442–453. Scholar
  60. Tang J, Xu H, Fan X et al (2008) Embryonic stem cell-derived neural precursor cells improve memory dysfunction in Aβ (1–40) injured rats. Neurosci Res 62(2):86–96. Scholar
  61. Taupin P (2006) Adult neural stem cells, neurogenic niches, and cellular therapy. Stem Cell Rev 2(3):213–219CrossRefGoogle Scholar
  62. Tolosa L, Pareja E, Gómez-Lechón MJ (2016) Clinical application of pluripotent stem cells: an alternative cell-based therapy for treating liver diseases? Transplantation 100(12):2548–2557. Scholar
  63. Wang Q, Matsumoto Y, Shindo T et al (2006) Neural stem cells transplantation in cortex in a mouse model of Alzheimer’s disease. J Med Investig 53(1–2):61–69. Scholar
  64. Wen SR, Qi HP, Ren YJ et al (2011) Expression of deltaNp73 in hippocampus of APP/PS1 transgenic mice following GFP-BMSCs transplantation. Neurol Res 33(10):1109–1114. Scholar
  65. Wimo A, Winblad B, Jönsson L (2010) The worldwide societal costs of dementia: estimates for 2009. Alzheimers Dement 6(2):98–103. Scholar
  66. Xuan AG, Luo M, Ji WD et al (2009) Effects of engrafted neural stem cells in Alzheimer’s disease rats. Neurosci Lett 450(2):167–171. Scholar
  67. Yagi T, Kosakai A, Ito D et al (2012) Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS One 7(7):e41572. Scholar
  68. Yang KL, Lee JT, Pang CY et al (2012) Human adipose-derived stem cells for the treatment of intracerebral hemorrhage in rats via femoral intravenous injection. Cell Mol Biol Lett 17(3):376. Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Nazish Tabassum
    • 1
  • Chandra Bhan Yadav
    • 1
  • Anshuman Singh
    • 2
  • Vinod Verma
    • 2
    Email author
  1. 1.Centre of Biotechnology, Nehru Science ComplexUniversity of AllahabadAllahabadIndia
  2. 2.Stem Cell Research Centre (SCRC), Department of HematologySanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS)LucknowIndia

Personalised recommendations